Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $100.6, along with a high estimate of $108.00 and a low estimate of $87.00. This upward ...

Palmolive's weak performance to continue in the near-term, with the mentioned challenges to persist in the second quarter as ...

Wall Street analysts forecast that Colgate-Palmolive (CL) will report quarterly earnings of $0.89 per share in its upcoming release, pointing to a year-over-year decline of 2.2%. It is anticipated ...

Colgate Palmolive India reported a decline in first-quarter profit on Tuesday, as feeble urban demand and intensified ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Colgate-Palmolive (CL) reports results for the quarter ended June 2025. While this widely-known consensus outlook is ...

Software platform DoubleVerify (DV) has announced that Colgate-Palmolive Australia has successfully leveraged DV’s pre-bid brand suitability controls to improve media quality across its video ...

Toothpaste maker Colgate-Palmolive raised the lower end of its annual sales and profit forecasts on Friday, after beating third-quarter estimates on resilient demand for its high-priced products.

Colgate-Palmolive's dividend yield of 2.2% is actually fairly low compared to some of its consumer products peers. From a big-picture standpoint, however, Colgate-Palmolive still yields more than ...

Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.

Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...

Colgate-Palmolive (CL) on Thursday announced a two-for-one split of the company's common stock and increased its quarterly cash dividend by 10%. Colgate stock closed at $115.35 a share Wednesday.

Colgate Palmolive’s net sales for the first nine months of 2012 stood at $2.3 billion, up more than 2% over the previous year. This growth was largely driven by a robust 6.5% increase in organic ...